Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 5
2016 5
2017 3
2018 1
2019 1
2020 1
2021 4
2022 4
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges.
Riva G, Nasillo V, Ottomano AM, Bergonzini G, Paolini A, Forghieri F, Lusenti B, Barozzi P, Lagreca I, Fiorcari S, Martinelli S, Maffei R, Marasca R, Potenza L, Comoli P, Manfredini R, Tagliafico E, Trenti T, Luppi M. Riva G, et al. Among authors: lagreca i. Cancers (Basel). 2021 Sep 12;13(18):4582. doi: 10.3390/cancers13184582. Cancers (Basel). 2021. PMID: 34572809 Free PMC article. Review.
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity.
Nasillo V, Lagreca I, Vallerini D, Barozzi P, Riva G, Maccaferri M, Paolini A, Forghieri F, Fiorcari S, Maffei R, Martinelli S, Atene CG, Castelli I, Marasca R, Potenza L, Comoli P, Manfredini R, Tagliafico E, Trenti T, Luppi M. Nasillo V, et al. Among authors: lagreca i. Cells. 2022 Mar 16;11(6):1003. doi: 10.3390/cells11061003. Cells. 2022. PMID: 35326454 Free PMC article.
The dynamic functions of IRF4 in B cell malignancies.
Maffei R, Fiorcari S, Atene CG, Martinelli S, Mesini N, Pilato F, Lagreca I, Barozzi P, Riva G, Nasillo V, Paolini A, Forghieri F, Potenza L, Trenti T, Tagliafico E, Luppi M, Marasca R. Maffei R, et al. Among authors: lagreca i. Clin Exp Med. 2023 Aug;23(4):1171-1180. doi: 10.1007/s10238-022-00968-0. Epub 2022 Dec 10. Clin Exp Med. 2023. PMID: 36495369 Free PMC article. Review.
Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia.
Forghieri F, Riva G, Lagreca I, Barozzi P, Bettelli F, Paolini A, Nasillo V, Lusenti B, Pioli V, Giusti D, Gilioli A, Colasante C, Galassi L, Catellani H, Donatelli F, Talami A, Maffei R, Martinelli S, Potenza L, Marasca R, Tagliafico E, Manfredini R, Trenti T, Comoli P, Luppi M. Forghieri F, et al. Among authors: lagreca i. Int J Mol Sci. 2021 Aug 25;22(17):9159. doi: 10.3390/ijms22179159. Int J Mol Sci. 2021. PMID: 34502069 Free PMC article. Review.
Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies.
Nasillo V, Riva G, Paolini A, Forghieri F, Roncati L, Lusenti B, Maccaferri M, Messerotti A, Pioli V, Gilioli A, Bettelli F, Giusti D, Barozzi P, Lagreca I, Maffei R, Marasca R, Potenza L, Comoli P, Manfredini R, Maiorana A, Tagliafico E, Luppi M, Trenti T. Nasillo V, et al. Among authors: lagreca i. Int J Mol Sci. 2021 Feb 14;22(4):1906. doi: 10.3390/ijms22041906. Int J Mol Sci. 2021. PMID: 33672997 Free PMC article. Review.
The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches.
Lagreca I, Riva G, Nasillo V, Barozzi P, Castelli I, Basso S, Bettelli F, Giusti D, Cuoghi A, Bresciani P, Messerotti A, Gilioli A, Pioli V, Colasante C, Vallerini D, Paolini A, Maccaferri M, Donatelli F, Forghieri F, Morselli M, Colaci E, Leonardi G, Marasca R, Potenza L, Manfredini R, Tagliafico E, Trenti T, Comoli P, Luppi M. Lagreca I, et al. Int J Mol Sci. 2022 May 8;23(9):5242. doi: 10.3390/ijms23095242. Int J Mol Sci. 2022. PMID: 35563634 Free PMC article. Review.
Characteristics and clinical behavior of acute myeloid leukemia harboring rare non-A/B/D nucleophosmin (NPM1) gene mutation subtypes: a single-center experience and review of the literature.
Mutti M, Cordella S, Parisotto A, Bettelli F, Morselli M, Cuoghi A, Bresciani P, Messerotti A, Gilioli A, Pioli V, Giusti D, Colaci E, Cassanelli L, Paolini A, Martinelli S, Maffei R, Riva G, Nasillo V, Sarti M, Trenti T, Comoli P, Tagliafico E, Manfredini R, Eccher A, Lagreca I, Barozzi P, Potenza L, Marasca R, Candoni A, Luppi M, Forghieri F. Mutti M, et al. Among authors: lagreca i. Leuk Lymphoma. 2024 Apr;65(4):511-515. doi: 10.1080/10428194.2023.2294695. Epub 2023 Dec 19. Leuk Lymphoma. 2024. PMID: 38112426 Review. No abstract available.
Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies.
Lagreca I, Nasillo V, Barozzi P, Castelli I, Basso S, Castellano S, Paolini A, Maccaferri M, Colaci E, Vallerini D, Natali P, Debbia D, Pirotti T, Ottomano AM, Maffei R, Bettelli F, Giusti D, Messerotti A, Gilioli A, Pioli V, Leonardi G, Forghieri F, Bresciani P, Cuoghi A, Morselli M, Manfredini R, Longo G, Candoni A, Marasca R, Potenza L, Tagliafico E, Trenti T, Comoli P, Luppi M, Riva G. Lagreca I, et al. Cancers (Basel). 2023 Feb 3;15(3):972. doi: 10.3390/cancers15030972. Cancers (Basel). 2023. PMID: 36765928 Free PMC article.
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms.
Forghieri F, Paolini A, Morselli M, Bigliardi S, Bonacorsi G, Leonardi G, Coluccio V, Maccaferri M, Fantuzzi V, Faglioni L, Colaci E, Soci F, Nasillo V, Messerotti A, Arletti L, Pioli V, Zucchini P, Quadrelli C, Corradini G, Giacobbi F, Vallerini D, Riva G, Barozzi P, Lagreca I, Marasca R, Narni F, Mecucci C, Ottaviani E, Martinelli G, Falini B, Luppi M, Potenza L. Forghieri F, et al. Among authors: lagreca i. Leuk Lymphoma. 2015;56(11):3222-6. doi: 10.3109/10428194.2015.1026900. Epub 2015 May 12. Leuk Lymphoma. 2015. PMID: 25813079 Review. No abstract available.
Adverse outcome associated with daratumumab-based treatments in relapsed/refractory multiple myeloma patients with amplification of chromosome arm 1q21: a single-center retrospective experience.
Barbieri E, Maccaferri M, Leonardi G, Giacobbi F, Corradini G, Lagreca I, Barozzi P, Potenza L, Marasca R, Luppi M. Barbieri E, et al. Among authors: lagreca i. Ann Hematol. 2022 Dec;101(12):2777-2779. doi: 10.1007/s00277-022-04978-6. Epub 2022 Sep 15. Ann Hematol. 2022. PMID: 36104630 Free PMC article. No abstract available.
23 results